Search results for

rco

Search within

Cat. # Tool Name Tool Category
161656 Anti-integrin a3 inhibiting Antibodies Key Info View Tool
161657 Anti-integrin a3 not inhibiting Antibodies Key Info View Tool
161658 Anti-integrin a4 [P3E3] Antibodies Key Info View Tool
161659 Anti-integrin a4 [P4C2] Antibodies Key Info View Tool
161660 Anti-integrin a4 [P4G9] Antibodies Key Info View Tool
161662 Anti-integrin b1 Antibodies Key Info View Tool
161717 Anti-TagRFP [6A11f] Antibodies Key Info View Tool
161764 TOV-21G cell line Cell lines Key Info View Tool
161765 OV-90 Cell Line Cell lines Key Info View Tool
161771 OV-1946 cell line Cell lines Key Info View Tool
161787 OV-4453 cell line Cell lines Key Info View Tool
161788 OV-4485 cell line Cell lines Key Info View Tool
161803 KPAR1.3 Cell Line Cell lines Key Info View Tool
161804 KPAR-G12C Cell Line Cell lines Key Info View Tool
161825 PC346C 15 [BIC J] CRPC Cell line Cell lines Key Info View Tool
161826 PC346C 16 [FLU C] CRPC Cell line Cell lines Key Info View Tool
161827 PC346C 17 [FLU H] CRPC Cell line Cell lines Key Info View Tool
161828 PC346C 18 [FLU K] CRPC Cell line Cell lines Key Info View Tool
161829 PC346C 19 [RD B] CRPC Cell line Cell lines Key Info View Tool
161830 PC346C 20 [RD C] CRPC Cell line Cell lines Key Info View Tool
161831 PC346C 21 [RD D] CRPC Cell line Cell lines Key Info View Tool
161832 PC346C 22 [RD E] CRPC Cell line Cell lines Key Info View Tool
161833 PC346C 23 [ABI A] CRPC Cell line Cell lines Key Info View Tool
161834 PC346C 24 [ABI B] CRPC Cell line Cell lines Key Info View Tool
161835 PC346C 25 [ABI C] CRPC Cell line Cell lines Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.